Vitality Biopharma Co-Founder Dr. Avtar Dhillon Resigns from Board of Directors Apr 25, 2019 12:00PM
Vitality Biopharma Appoints Former Ohio Governor Richard F. Celeste to Board Jan 24, 2019 03:56PM
Vitality Biopharma to Present at the 11th Annual LD Micro Main Event Dec 3, 2018 08:00AM
Vitality Biopharma Announces Corporate Updates and Completion of an SEC Examination Nov 21, 2018 07:00AM
Vitality Biopharma Inc. (VBIO) Announces $8.5M in Common Share Financing Oct 23, 2018 07:11AM


Oct 23, 2018 07:00AM Vitality Biopharma Receives $8.5 Million Common Stock Financing
Oct 3, 2018 07:00AM Vitality Biopharma Announces Neural Repair Treatment Patent Filings
Sep 13, 2018 06:30AM Vitality Biopharma Scientific Co-Founder to Present Recent Data at CannMed Medical Conference in Los Angeles
Aug 21, 2018 06:03AM Vitality Biopharma, Inc. (VBIO) Reports HC Prodrug VBX-100 Demonstrates Positive Safety Results
Aug 21, 2018 06:00AM Vitality Biopharma THC Prodrug VBX-100 Demonstrates Positive Safety Results
Jun 20, 2018 08:00AM Vitality Biopharma Receives DEA Renewal for Cannabinoid Pharma Development Program
Jun 5, 2018 09:00AM Vitality Biopharma Sponsors Clinical Research Forum on Ending Opioid Epidemic
May 30, 2018 09:00AM Vitality Biopharma to Present at the 8th Annual LD Micro Invitational
May 10, 2018 08:30AM Vitality Biopharma Discovers and Patents Use of Cannabinoids for C.diff-Associated Diarrhea and Colitis
Apr 5, 2018 09:00AM Vitality Biopharma Launches Canadian Subsidiary Focused on Cannabinoid Genetics R&D
Mar 28, 2018 08:30AM Vitality Biopharma Files Intellectual Property in All Major Pharmaceutical Markets Worldwide
Mar 19, 2018 08:00AM Vitality Biopharma CEO Robert Brooke Provides Shareholder Letter
Jan 17, 2018 08:00AM Vitality Biopharma Submits Orphan Drug Designation Request to FDA for Flagship THC Prodrug VITA-100
Jan 3, 2018 08:30AM Vitality Biopharma Introduces Cannabinoid Pharmaceutical VITA-100 as Prodrug of THC
Nov 1, 2017 07:00AM Vitality Biopharma Completes Pivotal GMP Manufacturing Agreements for Cannabinoid Pharmaceuticals
Oct 19, 2017 07:00AM Vitality Biopharma Announces Positive Results for Multiple Cannabinoid Drug Formulations in Treatment of IBD
Oct 16, 2017 07:00AM Vitality Biopharma Announces Publication of International PCT Patent Filing for Cannabinoid Pharmaceuticals
Oct 4, 2017 07:30AM Vitality Biopharma Achieves Cannabinoid Pharmaceutical Biosynthesis Breakthrough
Aug 23, 2017 08:47AM Vitality Biopharma to Present at The MoneyShow San Francisco Conference
Aug 2, 2017 08:30AM Vitality Biopharma Closes $1 Million Private Placement
Jul 19, 2017 09:00AM Vitality Biopharma Releases Positive Results for Treatment of Inflammatory Bowel Disease
Jun 21, 2017 08:30AM Vitality Biopharma Advisor to Present Pediatric IBD Case Study at ICRS2017 in Montreal
May 30, 2017 08:00AM Vitality Biopharma to Present at the 7th Annual LD Micro Invitational
May 17, 2017 08:00AM Vitality Biopharma Advisor to Present at 11th National Clinical Conference on Cannabis Therapeutics
May 3, 2017 08:00AM Vitality Biopharma Adds Key Clinical Advisors in Gastroenterology
Apr 20, 2017 08:00AM Vitality Biopharma Releases Clinical Report of Cannabinoid Therapy for Pediatric IBD
Apr 12, 2017 08:30AM Vitality Biopharma Appoints Pharma Industry Veteran to Advance Cannabosides Regulatory Development
Apr 5, 2017 09:00AM Vitality Biopharma Announces International Patent Filing for Neural Repair Treatments
Mar 30, 2017 09:00AM Vitality Biopharma Announces Positive Results for Colon Cancer
Mar 2, 2017 09:00AM Vitality Biopharma Announces Proprietary THC Pharmaceutical with Greatly Decreased Psychoactivity
Feb 16, 2017 08:55AM Vitality Biopharma to Present at SeeThruEquity 3rd Annual Innovations Investor Conference in Miami
Feb 1, 2017 09:00AM Vitality Biopharma Publishes Scientific Data on Discovery of Cannabinoid Glycosides
Jan 9, 2017 09:00AM Vitality Biopharma to Present at Biotech Showcase 2017
Dec 21, 2016 08:00AM Vitality Biopharma Receives DEA Approval for Cannabinoid Pharma Development Facility
Nov 16, 2016 08:00AM Vitality Biopharma Advances Cannabosides for Treatment of Narcotic Bowel Syndrome
Nov 9, 2016 09:00AM Vitality Biopharma Announces International Patent Filing for Cannabinoid Pharmaceuticals
Oct 19, 2016 09:00AM Vitality Biopharma Reports on Initial Cannabinoid Drug Formulation Studies
Sep 13, 2016 09:00AM Vitality Biopharma Develops Cannabinoid Alternatives to Opiate Prescription Pain Medications
Sep 12, 2016 01:49PM Vitality Biopharma to Present at Rodman & Renshaw 18th Annual Global Investment Conference
Aug 17, 2016 09:00AM Vitality Biopharma Begins Trading Under New Stock Symbol "VBIO"